The 4th AMR Accelerator Cross-project Meeting for the AMR Accelerator community, a total of 9 projects, took place on 15 Mach 2023 at the Marriott Hotel, Basel, Switzerland. Agenda: List of registered participants
People affected with bacterial infections can be involved in every step of antibiotic drug development. Not only can they be receiving an antibiotic treatment that derives from research results, but they can also be contributing partners of research, and even involved in further research. During this Science Communication Interest Group meeting, we explored community engagement […]
Please save the date for the upcoming 7th AMR Conference 2023! The #AMRconference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market. To stay informed visit the website here.
In commemoration of this year’s World TB Day, UNITE4TB partnered with ERA4TB to organize a webinar on the topic of community involvement and engagement in early-stage tuberculosis (TB) research. More info here.
The topic of the session was machine learning (ML) and artificial intelligence (AI) and how ML/AI tools are being utilized within the UNITE4TB Consortium to select, test and deliver novel combination TB regimens. Split into two parts, the first 30 minutes of the webinar was led by Dr. Carlos Talavera-López of Helmholtz Munich (co-lead of […]
Find out more and register here.
ESCMID and the Global Leaders Group on Antimicrobial Resistance will co-host a high-level symposia/conference free of charge on 14 April 2023, 15:00 -18:30 CEST, with the aim of strengthening the links between research, policy, and practice in order to develop sustainable solutions and a broader AMR research agenda. World leaders, policy makers, the private sector, civil society […]
